Featured Research

from universities, journals, and other organizations

Active management of the third stage of labor reduces risk of bleeding, study finds

Date:
November 15, 2010
Source:
University of Gothenburg
Summary:
Active management of the third stage of labor means that women lose less blood than with a more expectant approach, reveals new research from Sweden.

Active management of the third stage of labour means that women lose less blood than with a more expectant approach, reveals a thesis from the University of Gothenburg, Sweden, in conjunction with Sahlgrenska University Hospital.

A number of studies in the West have shown that heavy bleeding following childbirth has become more common in recent years. In her thesis, midwife and researcher Elisabeth Jangsten decided to look at how heavily women bleed after giving birth in Angola and Sweden following active and expectant management. The study in Angola covered 1,590 women, while the Swedish study included 1,802. The Swedish study was conducted at two of the delivery units at Sahlgrenska University Hospital, which make use of both active and expectant management.

Active management means that the umbilical cord is clamped straight after the baby is delivered, the midwife gives the mother medication to stimulate uterine contractions, presses a hand on the lower part of the uterus, and pulls gently on the umbilical cord while the mother pushes, so delivering the placenta. With an expectant approach, the umbilical cord is also clamped straight after the baby is delivered, but the midwife then waits for signals that the placenta has separated from the wall of the uterus before encouraging the mother to bear down and push out the placenta. Uterine stimulants are always given if the need arises.

"In Angola, 7.5% of women lost more than a litre of blood in the expectantly managed group, and only 1% in the actively managed group," says Jangsten, a midwife at Sahlgrenska University Hospital/Φstra Hospital and researcher at the Institute of Health and Care Sciences at the Sahlgrenska Academy. "In Sweden, the difference was bigger: almost 17% of women lost more than a litre in the expectantly managed group, and only 10% in the actively managed group."

The researchers did not find any difference between the two methods in terms of perceived afterpains in either Sweden or Angola. However, afterpains were more common the more children the women had had. They also found that first-time mothers in Sweden lost more blood and were more likely to require a blood transfusion than those who had given birth before. More women bled heavily in the Swedish study, which can be explained partly by all blood being measured carefully during the course of the study, but may also be down to other factors, such as excess weight, big babies and greater intervention during childbirth.

The recommendation in Sweden has been to give mothers uterine stimulants immediately after delivery.

"But not every element of the active management approach is always included, although the World Health Organisation, the International Confederation of Midwives and the International Federation of Gynaecology and Obstetrics have been recommending active management for a number of years, albeit with slightly later clamping of the umbilical cord," says Jangsten.

However, administering uterine stimulants routinely following all types of delivery has been questioned by those who believe that there should be as little medical intervention in childbirth as possible in order not to disrupt the natural process. They believe instead that treatment should be given only if the situation requires it.

"In the light of our results in this thesis, I think that active management should be the first choice for hospital deliveries. However, women should be informed about the different methods available so that they can be involved in decisions about the management of the third stage of labour if they so wish."


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Cite This Page:

University of Gothenburg. "Active management of the third stage of labor reduces risk of bleeding, study finds." ScienceDaily. ScienceDaily, 15 November 2010. <www.sciencedaily.com/releases/2010/11/101115174218.htm>.
University of Gothenburg. (2010, November 15). Active management of the third stage of labor reduces risk of bleeding, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/11/101115174218.htm
University of Gothenburg. "Active management of the third stage of labor reduces risk of bleeding, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/11/101115174218.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins